DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Li J, Yu K, Pang D. et al.
Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for triple-negative breast cancer (cbcsg010): An open-label, randomised, multicentre, phase 3 trial.
San Antonio Breast Cancer Symposium 2019;
2019: GS1-08
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.